Abstract 70P
Background
Methotrexate is an important component of acute lymphoblastic leukemia (ALL) protocols and methotrexate toxicity can at times lead to fatal complications which are unpredictable. Understanding gene polymorphisms is important as antidote to toxicity is not widely available and febrile neutropenia is deadly for patients with remote access to health care system in developing counties. This study was undertaken to analyse the toxicities in patients receiving high dose methotrexate and their association with methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms.
Methods
MTHFR gene polymorphisms (A1298C & C677T) were analysed using real time polymerase chain reaction on peripheral blood of patients with acute lymphoblastic leukemia receiving high dose methotrexate (HDMTx, methotrexate > 500 mg per square meter) and methotrexate toxicities were analysed. Statistical analysis was done by chi-square test.
Results
A total of 51patients received high dose methotrexate therapy, out of which 27 patients had MTHFR gene polymorphisms and 24 patients had no polymorphisms. Grade3 and 4 toxicities were seen in 16 of 51 patients (31%) of which 14patients (87.5%) had gene polymorphisms and 2 patients had no polymorphisms. All patients with toxicities having polymorphisms were heterozygous, A1298C in 9patients (64%), C677T in 5 patients (35%). Homozygous polymorphisms were not seen in any patient. A significant association was seen between MTHFR gene polymorphisms and methotrexate toxicity (p-value 0.000828) compared to those without polymorphisms.
Conclusions
Testing for MTHFR gene polymorphisms is important before starting high dose methotrexate as these patients need to be monitored carefully and dose adjustments need to be done to prevent morbidity and unpredictable mortality.
Editorial acknowledgement
Clinical trial identification
NA
Legal entity responsible for the study
NIMS, Hyderabad.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
62P - Role of IL6 (C-174G) polymorphism in the development of cervical intraepithelial neoplasia
Presenter: Tatyana Abakumova
Session: Cocktail & Poster Display session
Resources:
Abstract
63P - The impact of disruption of melatonin secretion on the structural-functional changes of the microbiome and the role of the melatonin-microbiome axis in the initiation of carcinogenesis
Presenter: Alexandre Tavartkiladze
Session: Cocktail & Poster Display session
Resources:
Abstract
64P - Acidosis induces ferroptosis of breast cancer via ZFAND5/SLC3A2 axis with the synergistic effect of metformin and facilitates M1 macrophage polarization
Presenter: Hanchu Xiong
Session: Cocktail & Poster Display session
Resources:
Abstract
65P - Transmembrane distribution of phosphatidylethanolamine in plasma membrane of ovarian cancer cells under conditions mimicking tumor microenvironment
Presenter: Darya Savenkova
Session: Cocktail & Poster Display session
Resources:
Abstract
66P - Metabolic regulation of GMP- and MDP-derived macrophages in glioblastoma
Presenter: Liam Wilson
Session: Cocktail & Poster Display session
Resources:
Abstract
67P - Inflammation status and sarcopenia synergistically impact outcomes in cancer patients (pt) treated with ImmunOtherapy (IO) within the framework of a Molecular Pre-screening program (MP) and a spEcial Medication (ME) program
Presenter: Lucia Notario Rincon
Session: Cocktail & Poster Display session
Resources:
Abstract
68P - The role of systemic reprogramming of GMPs in improving outcomes in glioblastoma
Presenter: Aline Atallah
Session: Cocktail & Poster Display session
Resources:
Abstract
69P - Integrated OMIC analysis reveals arginine and proline metabolism plays critical role in hypoxia-induced oral squamous cell carcinoma
Presenter: Avinash Singh
Session: Cocktail & Poster Display session
Resources:
Abstract
71P - Single nucleotide polymorphisms in the folate metabolic pathway genes and global DNA methylation in ovarian cancer
Presenter: Sandro Surmava
Session: Cocktail & Poster Display session
Resources:
Abstract
72P - Role of pyruvate carboxykinase 2 upregulation in group 3 medulloblastoma: Implications for metabolic reprogramming and therapeutic strategies
Presenter: MEDHA GAYATHRI PAI
Session: Cocktail & Poster Display session
Resources:
Abstract